XGN

Exagen (XGN)

About Exagen (XGN)

Exagen, Inc. is a commercial-stage diagnostics company, which engages in transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervention. It operates under the Avise brand. The company was founded by Waneta C. Tuttle and Cole Harris in 2002 and is headquartered in Vista, CA.

Details

Daily high

$7.04

Daily low

$6.72

Price at open

$7.01

52 Week High

$12.23

52 Week Low

$2.67

Market cap

159.3M

Dividend yield

0.00%

Volume

173,723

Avg. volume

254,395

P/E ratio

-7.59

Exagen News